Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas

Sarah J Larkin1, Francesco Ferraù2, Niki Karavitaki2

  • 1Nuffield Department of Clinical NeurosciencesDepartment of Neuropathology, Level 1 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UKDepartment of EndocrinologyBarts and London School of Medicine, Queen Mary University of London, London EC1A 6BQ, UKDepartment of EndocrinologyOxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington, Oxford OX3 7LE, UK sarah.larkin@ndcn.ox.ac.uk.

Abstract

Insights

Researchers investigated mutations in protein kinase A (PKA) genes, PRKACA and PRKACB, for sporadic somatotroph adenomas. No L206R mutations were found, suggesting this specific mutation is not involved in the disease.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Sporadic somatotroph adenomas' pathogenesis is unclear, but cAMP pathway dysregulation is suspected.
  • L206R mutations in PRKACA are found in adrenocortical adenomas, and PRKACB amplification in Carney complex-associated acromegaly.

Purpose of the Study:

  • To investigate the role of L206R mutations in PRKACA and PRKACB in the development of sporadic somatotroph adenomas.

Main Methods:

  • Analyzed DNA from 92 sporadic somatotroph adenoma specimens (1995-2012).
  • Determined PRKACA and PRKACB DNA sequence at codon 206 using PCR and sequencing.
  • Correlated findings with patient data, GNAS mutational status, and tumor granulation patterns.

Main Results:

  • No L206R mutations in PRKACA or PRKACB were detected in any of the 92 analyzed specimens.
  • Absence of mutation was consistent across wild-type and mutant GNAS cases and different tumor granulation patterns.

Conclusions:

  • The L206R mutation in PRKACA and PRKACB is unlikely to be a significant factor in sporadic somatotroph adenoma pathogenesis.
  • While less probable, other genetic alterations like gene amplification or mutations in different cAMP pathway components cannot be entirely excluded.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K